Erdoxol 300 Capsule contains Erdosteine 300 mg, a well-established mucolytic agent that works by breaking disulfide bonds in mucus, thereby reducing its viscosity and improving clearance from the respiratory tract. This action facilitates easier expectoration and improves airway patency.
Clinically, Erdosteine is indicated for acute and chronic respiratory conditions such as chronic bronchitis, COPD, productive cough, and respiratory tract infections where thick mucus contributes to airway obstruction and breathing difficulty. It also exhibits antioxidant and anti-inflammatory properties, supporting respiratory mucosal health.
The capsule formulation ensures accurate dosing, stable bioavailability, and consistent therapeutic action, making it suitable for pulmonology clinics, hospitals, general practice, and long-term respiratory care. Oral administration allows convenient dosing and good patient adherence.
Erdoxol 300 Capsule helps in relieving chest congestion, improving cough productivity, and enhancing overall respiratory comfort. With its proven efficacy and favorable safety profile, it remains a trusted mucolytic therapy option under appropriate medical supervision.